PortfoliosLab logoPortfoliosLab logo
GRFS vs. JNJ
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GRFS vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Grifols, S.A. (GRFS) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GRFS achieves a -22.14% return, which is significantly lower than JNJ's 13.00% return. Over the past 10 years, GRFS has underperformed JNJ with an annualized return of -6.28%, while JNJ has yielded a comparatively higher 10.15% annualized return.


GRFS

1D
-1.62%
1M
-8.77%
YTD
-22.14%
6M
-19.82%
1Y
-15.59%
3Y*
-6.06%
5Y*
-15.65%
10Y*
-6.28%

JNJ

1D
1.27%
1M
-0.73%
YTD
13.00%
6M
12.80%
1Y
58.27%
3Y*
15.12%
5Y*
10.36%
10Y*
10.15%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GRFS vs. JNJ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
GRFS
Grifols, S.A.
-22.14%27.79%-35.64%36.00%-24.31%-37.82%-20.10%29.06%-18.28%44.48%
JNJ
Johnson & Johnson
13.00%47.48%-4.81%-8.58%5.97%11.44%10.82%16.22%-5.13%24.43%

Correlation

The correlation between GRFS and JNJ is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (10Y)
Calculated over the trailing 10-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Jun 2, 2011

0.23

The correlation between GRFS and JNJ shifts across timeframes, from 0.12 (3 years) to 0.23 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

GRFS:

$4.95B

JNJ:

$565.55B

EPS

GRFS:

€0.61

JNJ:

$8.65

PE Ratio

GRFS:

10.46

JNJ:

26.75

PEG Ratio

GRFS:

0.17

JNJ:

0.89

PS Ratio

GRFS:

0.58

JNJ:

5.84

PB Ratio

GRFS:

0.79

JNJ:

6.97

Total Revenue (TTM)

GRFS:

€7.45B

JNJ:

$96.36B

Gross Profit (TTM)

GRFS:

€2.81B

JNJ:

$66.60B

EBITDA (TTM)

GRFS:

€1.56B

JNJ:

$31.62B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GRFS vs. JNJ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GRFS
GRFS Risk / Return Rank: 2222
Overall Rank
GRFS Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
GRFS Sortino Ratio Rank: 2020
Sortino Ratio Rank
GRFS Omega Ratio Rank: 2121
Omega Ratio Rank
GRFS Calmar Ratio Rank: 2525
Calmar Ratio Rank
GRFS Martin Ratio Rank: 2424
Martin Ratio Rank

JNJ
JNJ Risk / Return Rank: 9595
Overall Rank
JNJ Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
JNJ Sortino Ratio Rank: 9898
Sortino Ratio Rank
JNJ Omega Ratio Rank: 9696
Omega Ratio Rank
JNJ Calmar Ratio Rank: 9393
Calmar Ratio Rank
JNJ Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GRFS vs. JNJ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Grifols, S.A. (GRFS) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GRFSJNJDifference
Sharpe ratioReturn per unit of total volatility

-3.92

Sortino ratioReturn per unit of downside risk

-5.38

Omega ratioGain probability vs. loss probability

0.94

1.61

-0.67

Calmar ratioReturn relative to maximum drawdown

-0.49

5.34

-5.83

Martin ratioReturn relative to average drawdown

-0.89

15.57

-16.46

GRFS vs. JNJ - Sharpe Ratio Comparison

The current GRFS Sharpe Ratio is -0.49, which is lower than the JNJ Sharpe Ratio of 3.42. The chart below compares the historical Sharpe Ratios of GRFS and JNJ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GRFS vs. JNJ - Drawdown Comparison

The maximum GRFS drawdown since its inception was -78.01%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for GRFS and JNJ.


Loading charts...

Drawdown Indicators


GRFSJNJDifference

Max Drawdown

Largest peak-to-trough decline

-78.01%

-50.67%

-27.34%

Max Drawdown (1Y)

Largest decline over 1 year

-32.22%

-10.96%

-21.26%

Max Drawdown (3Y)

Largest decline over 3 years

-52.68%

-15.95%

-36.73%

Max Drawdown (5Y)

Largest decline over 5 years

-69.29%

-18.41%

-50.88%

Max Drawdown (10Y)

Largest decline over 10 years

-78.01%

-27.37%

-50.64%

Current Drawdown

Current decline from peak

-70.24%

-6.41%

-63.83%

Average Drawdown

Average peak-to-trough decline

-31.83%

-11.90%

-19.93%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.58%

3.75%

+13.83%

Volatility

GRFS vs. JNJ - Volatility Comparison

Grifols, S.A. (GRFS) has a higher volatility of 6.88% compared to Johnson & Johnson (JNJ) at 6.32%. This indicates that GRFS's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GRFSJNJDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.88%

6.32%

+0.56%

Volatility (6M)

Calculated over the trailing 6-month period

24.38%

12.32%

+12.06%

Volatility (1Y)

Calculated over the trailing 1-year period

31.82%

17.14%

+14.68%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

48.78%

16.92%

+31.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

40.32%

18.51%

+21.81%

Dividends

GRFS vs. JNJ - Dividend Comparison

GRFS's dividend yield for the trailing twelve months is around 2.41%, more than JNJ's 2.27% yield.


PositionTTM20252024202320222021202020192018201720162015
GRFS
Grifols, S.A.
2.41%1.88%0.00%0.00%0.00%3.20%0.83%1.55%2.32%1.24%1.67%2.01%
JNJ
Johnson & Johnson
2.27%2.48%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%

Financials

GRFS vs. JNJ - Financials Comparison

This section allows you to compare key financial metrics between Grifols, S.A. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B25.00B20222023202420252026
1.73B
24.06B
(GRFS) Total Revenue
(JNJ) Total Revenue
Please note, different currencies. GRFS values in EUR, JNJ values in USD

GRFS vs. JNJ - Profitability Comparison

The chart below illustrates the profitability comparison between Grifols, S.A. and Johnson & Johnson over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%20222023202420252026
36.5%
71.5%
Portfolio components
GRFS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Grifols, S.A. reported a gross profit of 630.20M and revenue of 1.73B. Therefore, the gross margin over that period was 36.5%.

JNJ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.

GRFS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Grifols, S.A. reported an operating income of 253.09M and revenue of 1.73B, resulting in an operating margin of 14.7%.

JNJ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.

GRFS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Grifols, S.A. reported a net income of 74.20M and revenue of 1.73B, resulting in a net margin of 4.3%.

JNJ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.


Frequently Asked Questions


GRFS and JNJ have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GRFS has higher volatility (6.88%) compared to JNJ (6.32%). In terms of maximum drawdown, GRFS dropped -78.01% vs JNJ's -50.67%.

JNJ currently has the higher Sharpe Ratio (3.42 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GRFS and JNJ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer